Churn‐Shiouh Gau

1.2k total citations
52 papers, 902 citations indexed

About

Churn‐Shiouh Gau is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Churn‐Shiouh Gau has authored 52 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 9 papers in Psychiatry and Mental health and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Churn‐Shiouh Gau's work include Pharmaceutical Economics and Policy (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmacovigilance and Adverse Drug Reactions (6 papers). Churn‐Shiouh Gau is often cited by papers focused on Pharmaceutical Economics and Policy (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmacovigilance and Adverse Drug Reactions (6 papers). Churn‐Shiouh Gau collaborates with scholars based in Taiwan, United States and Singapore. Churn‐Shiouh Gau's co-authors include Susan Shur‐Fen Gau, Fei‐Yuan Hsiao, Lin‐Chau Chang, George Zografi, Yen‐Nan Chiu, Yueh‐Ming Tai, Li‐Jiuan Shen, Chia‐Yu Lin, Fe‐Lin Lin Wu and Yi‐Wen Tsai and has published in prestigious journals such as Blood, PLoS ONE and Journal of Colloid and Interface Science.

In The Last Decade

Churn‐Shiouh Gau

50 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Churn‐Shiouh Gau Taiwan 19 299 134 118 90 87 52 902
Elin Haf Davies United Kingdom 15 153 0.5× 284 2.1× 138 1.2× 129 1.4× 71 0.8× 53 1.4k
Mehmet Burcu United States 20 485 1.6× 317 2.4× 141 1.2× 22 0.2× 121 1.4× 56 1.2k
Jeannette Y. Wick United States 11 101 0.3× 57 0.4× 232 2.0× 40 0.4× 24 0.3× 109 876
Chang Park United States 20 92 0.3× 136 1.0× 90 0.8× 18 0.2× 27 0.3× 70 1.1k
Björn M. Nilsson Sweden 17 113 0.4× 44 0.3× 197 1.7× 116 1.3× 26 0.3× 46 1.0k
Ilana M. Braun United States 18 178 0.6× 116 0.9× 63 0.5× 22 0.2× 29 0.3× 60 1.4k
W. Satterlee United States 14 884 3.0× 151 1.1× 322 2.7× 52 0.6× 92 1.1× 29 2.6k
Nicola Roberts United Kingdom 25 55 0.2× 225 1.7× 210 1.8× 65 0.7× 42 0.5× 81 1.8k
Vera Mastey United States 16 449 1.5× 62 0.5× 47 0.4× 16 0.2× 191 2.2× 43 1.7k
J Bryant United Kingdom 20 86 0.3× 109 0.8× 106 0.9× 23 0.3× 193 2.2× 32 1.4k

Countries citing papers authored by Churn‐Shiouh Gau

Since Specialization
Citations

This map shows the geographic impact of Churn‐Shiouh Gau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Churn‐Shiouh Gau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Churn‐Shiouh Gau more than expected).

Fields of papers citing papers by Churn‐Shiouh Gau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Churn‐Shiouh Gau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Churn‐Shiouh Gau. The network helps show where Churn‐Shiouh Gau may publish in the future.

Co-authorship network of co-authors of Churn‐Shiouh Gau

This figure shows the co-authorship network connecting the top 25 collaborators of Churn‐Shiouh Gau. A scholar is included among the top collaborators of Churn‐Shiouh Gau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Churn‐Shiouh Gau. Churn‐Shiouh Gau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chih‐Fen, et al.. (2024). Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms. Journal of the Formosan Medical Association. 123. S169–S179.
2.
Liu, Yu‐Hsuan, et al.. (2023). Regulatory considerations for generic products of non-biological complex drugs. Journal of Food and Drug Analysis. 31(1). 20–31. 6 indexed citations
3.
Gau, Churn‐Shiouh, et al.. (2020). Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan. International Journal of Technology Assessment in Health Care. 37(1). e26–e26. 3 indexed citations
4.
Lin, Fang‐Ju, Churn‐Shiouh Gau, Nan Luo, et al.. (2018). Valuation of the EQ-5D-5L in Taiwan. PLoS ONE. 13(12). e0209344–e0209344. 49 indexed citations
5.
Gau, Churn‐Shiouh, et al.. (2018). Analysis of refuse-to-file policy for generic drug application in Taiwan. Regulatory Toxicology and Pharmacology. 94. 33–39. 1 indexed citations
6.
Chang, Lin‐Chau, Jaw‐Jou Kang, & Churn‐Shiouh Gau. (2016). Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan. Regulatory Toxicology and Pharmacology. 77. 252–256. 2 indexed citations
7.
Gau, Churn‐Shiouh, et al.. (2015). APEC Workshop Report of Good Review Practices on Medical Products. Therapeutic Innovation & Regulatory Science. 49(4). 483–492. 2 indexed citations
8.
Chiu, Wen‐Ta, Raoh‐Fang Pwu, & Churn‐Shiouh Gau. (2015). Affordable health technology assessment in Taiwan: A model for middle-income countries. Journal of the Formosan Medical Association. 114(6). 481–483. 5 indexed citations
9.
Chen, Shih‐Chin, Fei‐Yuan Hsiao, Chi‐Ming Lee, William Hsu, & Churn‐Shiouh Gau. (2014). Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome. BMC Cardiovascular Disorders. 14(1). 21–21. 1 indexed citations
10.
Hsiao, Fei‐Yuan, et al.. (2013). Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study. Drug Safety. 36(8). 643–649. 51 indexed citations
11.
Lin, Yu‐Li, Yen‐Hung Lin, Vin‐Cent Wu, et al.. (2013). The Impact of Metabolic Syndrome, Homocysteine, and B Vitamins on Carotid Artery Intima-Media Thickness in Hypertensive Patients.. PubMed. 29(1). 56–63. 2 indexed citations
12.
Shen, Li‐Jiuan, et al.. (2012). Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan. British Journal of Clinical Pharmacology. 74(5). 824–834. 21 indexed citations
13.
Gau, Churn‐Shiouh, et al.. (2010). Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case‐control study. Bipolar Disorders. 12(3). 253–263. 26 indexed citations
14.
Sun, Hsin‐Yun, et al.. (2009). A Prospective Study of Hepatitis During Antituberculous Treatment in Taiwanese Patients and a Review of the Literature. Journal of the Formosan Medical Association. 108(2). 102–111. 21 indexed citations
15.
Lin, Yen‐Hung, Wei‐Shiung Yang, Vin‐Cent Wu, et al.. (2008). Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease. Clinical Chemistry and Laboratory Medicine (CCLM). 46(1). 125–30. 14 indexed citations
16.
Chang, Lin‐Chau, et al.. (2008). Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers. Journal of Colloid and Interface Science. 322(1). 263–273. 40 indexed citations
17.
Gau, Susan Shur‐Fen, et al.. (2006). Determinants of Adherence to Methylphenidate and the Impact of Poor Adherence on Maternal and Family Measures. Journal of Child and Adolescent Psychopharmacology. 16(3). 286–297. 123 indexed citations
18.
Gau, Susan Shur‐Fen, et al.. (2006). An Open-Label, Randomized, Active-Controlled Equivalent Trial of Osmotic Release Oral System Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder in Taiwan. Journal of Child and Adolescent Psychopharmacology. 16(4). 441–455. 67 indexed citations
19.
Lin, Yen‐Hung, Vin‐Cent Wu, Yu‐Li Lin, et al.. (2006). The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine. Clinical Biochemistry. 40(3-4). 230–234. 11 indexed citations
20.
Tsai, Hsing-Chen, Yuang‐Shuang Liaw, Ying‐Jung Chen, et al.. (2004). Management of Anti-tuberculosis Drug-related Hepatotoxicity: Comparison of the Fluoroquinolone-containing Regimen and Re-challenge with the Standard Regimen. 19(6). 453–462. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elin Haf Davies Breakdown of academic impact, for papers by Mehmet Burcu Breakdown of academic impact, for papers by Jeannette Y. Wick Breakdown of academic impact, for papers by Chang Park Breakdown of academic impact, for papers by Björn M. Nilsson Breakdown of academic impact, for papers by Ilana M. Braun Breakdown of academic impact, for papers by W. Satterlee Breakdown of academic impact, for papers by Nicola Roberts Breakdown of academic impact, for papers by Vera Mastey Breakdown of academic impact, for papers by J Bryant
Rankless by CCL
2026